Phio Pharmaceuticals
PHIOPhio Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Phio Pharmaceuticals
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 2/26/2024 | Buy | Bitterman, Robert J. | President & CEO | $0.9 | $2,275 |
| 7/1/2023 | Buy | Bitterman, Robert J. | President & CEO | $2.8 | $2,840 |
| 6/30/2023 | Buy | Bitterman, Robert J. | President & CEO | $2.9 | $2,880 |
| 6/14/2023 | Buy | Ferrara, Robert L. | Director | $3.1 | $6,200 |
| 12/14/2022 | Buy | Bitterman, Robert J. | Interim Executive Chairman | $0.4 | $780 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)